| 000 | 01875 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516174408.0 | ||
| 264 | 0 | _c20140519 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a2045-7634 | ||
| 024 | 7 |
_a10.1002/cam4.47 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChretien, Anne-Sophie | |
| 245 | 0 | 0 |
_aOptimization of routine KRAS mutation PCR-based testing procedure for rational individualized first-line-targeted therapy selection in metastatic colorectal cancer. _h[electronic resource] |
| 260 |
_bCancer medicine _cFeb 2013 |
||
| 300 |
_a11-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDNA Mutational Analysis _xmethods |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNucleic Acid Denaturation |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPolymerase Chain Reaction _xmethods |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
| 650 | 0 | 4 | _aProto-Oncogene Proteins p21(ras) |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 |
_aras Proteins _xgenetics |
| 700 | 1 | _aHarlé, Alexandre | |
| 700 | 1 | _aMeyer-Lefebvre, Magali | |
| 700 | 1 | _aRouyer, Marie | |
| 700 | 1 | _aHusson, Marie | |
| 700 | 1 | _aRamacci, Carole | |
| 700 | 1 | _aHarter, Valentin | |
| 700 | 1 | _aGenin, Pascal | |
| 700 | 1 | _aLeroux, Agnès | |
| 700 | 1 | _aMerlin, Jean-Louis | |
| 773 | 0 |
_tCancer medicine _gvol. 2 _gno. 1 _gp. 11-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cam4.47 _zAvailable from publisher's website |
| 999 |
_c23178618 _d23178618 |
||